OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
7,899,621
Share change
+35,634
Total reported value
$127,044,672
Put/Call ratio
204%
Price per share
$16.08
Number of holders
68
Value change
+$572,511
Number of buys
2
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q4 2013

As of 31 Dec 2013, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,899,621 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, State Street Corp, LORD, ABBETT & CO. LLC, NORTHERN TRUST CORP, and PUTNAM INVESTMENTS LLC. This page lists 68 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.